Top compounds associated with response to TIGD3

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	manumycin A	CTRPv2	pan-cancer	AAC	0.2	2e-09
mRNA	decitabine:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.19	3e-09
mRNA	doxorubicin:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.2	4e-09
mRNA	vorinostat:navitoclax (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.21	5e-09
mRNA	Topotecan	CTRPv2	pan-cancer	AAC	0.19	5e-09
mRNA	BRD-A02303741:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.21	7e-09
mRNA	NPK76-II-72-1	GDSC1000	pan-cancer	AAC	0.17	2e-08
mRNA	BRD-K28456706	CTRPv2	pan-cancer	AAC	0.21	3e-08
mRNA	navitoclax:PLX-4032 (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.2	3e-08
mRNA	Docetaxel	GDSC1000	pan-cancer	AAC	-0.18	3e-08

Download CSV